ArticleBMC ophthalmology2026
Phacoemulsification combined with bent ab interno needle goniectomy versus high-frequency deep sclerotomy: a comparative study of surgical outcomes in open-angle glaucoma.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to compare intraocular pressure (IOP) reduction, surgical success, antiglaucoma medication (AGM) usage, complication profiles, and structural and functional outcomes between phacoemulsification combined with bent ab interno needle goniectomy (Phaco-BANG) and high-frequency deep sclerotomy (Phaco-HFDS) in patients with open-angle glaucoma (OAG), given the lack of direct head-to-head comparisons.
methodsThis retrospective comparative study included 70 eyes from 70 patients (35 per group). The primary outcome was the change in IOP from baseline to postoperative month 12. Secondary outcomes included surgical success rate, changes in AGM use, complications, and structural and functional parameters, such as retinal nerve fiber layer (RNFL) thickness, central macular thickness (CMT), and visual field mean deviation (MD). Surgical success was defined as a reduction in AGM without an increase in IOP, or an IOP of ≤21 mmHg with a ≥ 20% reduction from baseline.
resultsAt 12 months, mean IOP decreased by -4.3 ± 5.2 mmHg in the Phaco-BANG group and -4.0 ± 4.3 mmHg in the Phaco-HFDS group. Both groups showed significant IOP reduction at all postoperative time points compared to baseline (p < 0.05), with no statistically significant differences between groups (p > 0.05). Surgical success (IOP ≤ 21 mmHg with ≥20% reduction and/or ≥1 medication reduction without IOP increase) was achieved in 80.0% and 77.1% of eyes in the Phaco-BANG and Phaco-HFDS groups, respectively, with similar Kaplan-Meier survival outcomes (all p > 0.05). AGM use was also significantly reduced in both groups, with no statistically significant differences between groups (p > 0.05). The mean reduction in AGM at 12 months was -2.1 ± 1.3 in the Phaco-BANG group and -1.4 ± 0.9 in the Phaco-HFDS group (p = 0.143). No statistically significant differences were observed between the groups regarding structural and functional outcomes. Early postoperative complications were more frequent in the Phaco-BANG group, primarily due to transient hyphema; however, no vision-threatening complications or need for additional glaucoma surgery occurred.
conclusionsBoth Phaco-BANG and Phaco-HFDS were associated with reductions in IOP and AGM use at 12 months in patients with OAG. No statistically significant differences were observed between the two groups regarding IOP reduction, medication burden, surgical success rates, or structural and functional outcomes. Although transient hyphema was more common following Phaco-BANG, both procedures demonstrated favorable safety profiles.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.